Industry Interactions at Medical Conferences: Representatives’ Credentials and the Disclosure of Data Limitations Influence Clinician Perceptions
Open Access
- 1 July 2025
- journal article
- Published by American Board of Family Medicine (ABFM) in The Journal of the American Board of Family Medicine
- Vol. 38 (4) , 716-725
Abstract
Purpose: Exhibit hall booths at medical conferences are a key avenue for promoting prescription drugs to health care providers (HCPs). Because HCPs spend considerable time interacting with industry representatives at conferences, we explored how representatives’ credentials might influence HCP perceptions and prescribing intentions of promoted drugs. We also examined how disclosures of clinical trial data limitations about these drugs during conference interactions might influence HCP perceptions and intentions. Methods: We conducted a 2 × 2 factorial experimental study with HCPs (n = 430) during or immediately after their attendance at 1 of 12 US medical conferences. Participants viewed video stimuli depicting an exhibit hall interaction between an industry representative and an HCP discussing a fictitious drug for preventing nausea and vomiting. Participants were randomly assigned to 1 of 4 experimental conditions that varied (1) the representative’s educational credentials (MBA vs MD) and (2) a disclosure noting clinical trial data limitations (present vs absent). Participants then completed an online questionnaire with questions about the fictitious drug, such as perceived efficacy and perceived risk. Results: Industry representative credentials had no influence on HCP perceptions and intentions to prescribe the drug, though representatives with medical degrees were rated as having slightly more medical knowledge. Conversely, the disclosure significantly reduced drug efficacy perceptions and led to less positive drug attitudes, although it did not influence prescribing intentions. Conclusions: The findings suggest that HCP perceptions and intentions are not swayed by the industry representative credentials but that data limitation disclosures can temper HCP perceptions of drugs promoted at medical conferences.Keywords
This publication has 14 references indexed in Scilit:
- Influence of data disclosures on physician decisions about off-label uses: findings from a qualitative studyBMC Primary Care, 2022
- The effects of similarity, parasocial identification, and source credibility in obesity public service announcements on diet and exercise self-efficacyJournal of Health Psychology, 2014
- Health Information, Credibility, Homophily, and Influence via the Internet: Web Sites Versus Discussion GroupsHealth Communication, 2008
- Product expertise versus professional expertise: Congruency between an endorser's chosen profession and the endorsed productJournal of Targeting, Measurement and Analysis for Marketing, 2008
- The Persuasiveness of Source Credibility: A Critical Review of Five Decades' EvidenceJournal of Applied Social Psychology, 2004
- Source expertise versus experience effects in hospital advertisingJournal of Services Marketing, 1998
- The Elaboration Likelihood Model of Persuasion1986
- The Persuasive Effect of Source Credibility: Tests of Cognitive ResponseJournal of Consumer Research, 1978
- Dimensions for Evaluating the Acceptability of Message SourcesPublic Opinion Quarterly, 1969
- The Influence of Source Credibility on Communication EffectivenessPublic Opinion Quarterly, 1951